Soros Fund Management - CAESARS ENTMT CORP ownership

CAESARS ENTMT CORP's ticker is CZRXXXX and the CUSIP is 127686103. A total of 1 filers reported holding CAESARS ENTMT CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Soros Fund Management ownership history of CAESARS ENTMT CORP
ValueSharesWeighting
Q2 2020$42,449,000
+477.4%
3,499,528
+221.8%
0.95%
+154.6%
Q1 2020$7,352,000
-65.4%
1,087,585
-30.4%
0.37%
-45.9%
Q4 2019$21,251,000
-85.8%
1,562,577
-87.8%
0.69%
-83.4%
Q3 2019$149,659,000
-33.5%
12,835,265
-32.6%
4.15%
-21.3%
Q2 2019$225,096,000
+4.4%
19,043,658
-23.3%
5.27%
+5.3%
Q1 2019$215,700,000
-4.2%
24,821,642
-25.1%
5.00%
-26.6%
Q4 2018$225,161,000
-36.3%
33,160,623
-3.9%
6.82%
-12.1%
Q3 2018$353,609,000
-4.2%
34,498,3950.0%7.76%
+31.3%
Q2 2018$369,133,000
-4.9%
34,498,3950.0%5.91%
-6.3%
Q1 2018$388,107,000
-11.1%
34,498,3950.0%6.30%
-36.8%
Q4 2017$436,405,000
+1005.7%
34,498,395
+1066.9%
9.98%
+963.0%
Q3 2017$39,468,000
+11.2%
2,956,4170.0%0.94%
+48.8%
Q2 2017$35,477,000
+25.7%
2,956,4170.0%0.63%
+10.9%
Q1 2017$28,234,000
+12.4%
2,956,4170.0%0.57%
-2.2%
Q4 2016$25,130,000
+2.2%
2,956,417
-10.4%
0.58%
-5.4%
Q3 2016$24,595,000
-3.1%
3,301,3930.0%0.62%
+13.3%
Q2 2016$25,388,000
-25.6%
3,301,393
-34.2%
0.54%
-27.9%
Q1 2016$34,125,000
-13.8%
5,018,4270.0%0.75%
+15.0%
Q4 2015$39,595,000
+34.0%
5,018,4270.0%0.66%
+46.5%
Q3 2015$29,559,000
-6.5%
5,018,427
-2.9%
0.45%
+52.0%
Q2 2015$31,618,000
-29.6%
5,166,327
+21.1%
0.29%
-33.5%
Q1 2015$44,924,000
-41.4%
4,266,327
-12.7%
0.44%
-47.2%
Q4 2014$76,695,000
-7.7%
4,888,127
-26.0%
0.84%
+35.0%
Q3 2014$83,083,000
-30.4%
6,604,3830.0%0.62%
-31.1%
Q2 2014$119,408,000
-3.6%
6,604,383
+1.4%
0.90%
-26.5%
Q1 2014$123,846,000
-10.9%
6,514,783
+0.9%
1.22%
+3.6%
Q4 2013$139,028,000
+24.7%
6,454,383
+14.1%
1.18%
-3.1%
Q3 2013$111,449,000
+35.8%
5,654,383
-5.6%
1.22%
+37.0%
Q2 2013$82,041,0005,988,3420.89%
Other shareholders
CAESARS ENTMT CORP shareholders Q3 2023
NameSharesValueWeighting ↓
CIBC WORLD MARKETS CORP 38,696$1,793,5600.02%
View complete list of CAESARS ENTMT CORP shareholders